Status:
COMPLETED
Short Term Effects of FX Dialysers on QOL and Inflammation
Lead Sponsor:
Sir Charles Gairdner Hospital
Conditions:
Kidney Failure, Chronic
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Background: The new hollow fibre FX-class of dialysers (Fresenius Medical Care, Bad Homburg, Germany) features a number of technological improvements that may benefit the patient. This includes the u...
Detailed Description
Methods Patient selection All patients in the Joondalup Health Campus satellite dialysis unit will be invited to participate in this study. Inclusion criteria - 1. Age \>18years 2. Able to provide i...
Eligibility Criteria
Inclusion
- Age \>18years
- Able to provide informed consent
- On haemodialysis for 3 months
Exclusion
- Active inflammatory, infective or neoplastic process within the last 1 month
- Active major psychiatric condition
- Currently on haemodiafiltration as haemodialysis modality
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00291603
Start Date
February 1 2006
End Date
December 1 2006
Last Update
April 25 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Joondalup Health Campus Satellite Dialysis Unit
Perth, Western Australia, Australia, 6050